Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.410
-0.030 (-2.08%)
At close: Dec 26, 2025, 4:00 PM EST
1.400
-0.010 (-0.71%)
After-hours: Dec 26, 2025, 7:57 PM EST
Ocugen Market Cap
Ocugen has a market cap or net worth of $440.37 million as of December 26, 2025. Its market cap has increased by 71.15% in one year.
Market Cap
440.37M
Enterprise Value
440.77M
1-Year Change
71.15%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $440.37M, an increase of 1,244.67%. That is a compound annual growth rate of 51.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 440.37M | 87.78% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | 296.51M | 983.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |